ODTX Odyssey Therapeutics, Inc.

ODTX financial statements, revenue, balance sheet, cash flow, and SEC filings

CIK: 1882782 Exchange: Nasdaq SIC: 2836 (Biological Products, (No Diagnostic Substances)) Latest filing: 10-Q filed Aug 6, 2026 Data checked: Oct 21, 2026

Showing 0 of 0 annual and 0 of 2 quarterly periods. Full history available with a free account or via API.

▼ Company Profile

Filer Category

<br>Emerging growth company

Entity Type

Operating

Industry (SIC)

2836 Biological Products, (No Diagnostic Substances)

Incorporated

Fiscal Year End

December (1231)

Phone

(212) 841-1000

EIN

863384382

Headquarters

BOSTON, MA, 02210

Sources and calculation details

Reported values are preserved. Derived values use the listed inputs; unavailable inputs remain blank.

Field-level sources for this historical record are unavailable until it is rebuilt from SEC facts.

Annual (FY)

Quarterly 🔒

Chart 🔒

No annual data available.

Create a free account to see full history, quarterly data, charts, CSV downloads, and API access.

Create Free Account Log In

🔒

Quarterly data and charts require a free account

Get access to 8 quarters of data, interactive charts, CSV downloads, and API access.

Create Free Account Log In

Related Companies

Biological Products, (No Diagnostic Substances)

ABOS Acumen Pharmaceuticals, Inc. ABP Abpro Holdings, Inc. ACLX Arcellx, Inc. ACOG Alpha Cognition Inc. ADAPY Adaptimmune Therapeutics PLC ADMA ADMA BIOLOGICS, INC.